Adolescent cocaine exposure simplifies orbitofrontal cortical dendritic arbors

Lauren M DePoy1, Riley E Perszyk2, Kelsey S Zimmermann1

  • 1Department of Pediatrics, Emory University School of Medicine , Atlanta, GA, USA ; Yerkes National Primate Research Center, Emory University , Atlanta, GA, USA ; Graduate Program in Neuroscience, Emory University , Atlanta, GA, USA.

Frontiers in Pharmacology
|December 3, 2014
PubMed

Insights

Adolescent cocaine exposure alters orbitofrontal cortex (oPFC) neuron structure, leading to long-term changes in dendrite complexity. These cocaine-induced structural modifications, rather than pre-existing differences, likely drive behavioral vulnerabilities to drugs of abuse.

Area of Science:

  • Neuroscience
  • Neurobiology
  • Developmental Neuroscience

Background:

  • Cocaine and amphetamine alter dendritic spines in brain regions like the orbitofrontal cortex (oPFC).
  • The impact of these drugs on dendrite structure and the role of pre-existing cellular traits in vulnerability to substance abuse are not fully understood.
  • Animal models allow for pre- and post-drug exposure assessment of neurobehavioral phenotypes.

Purpose of the Study:

  • To investigate the long-term effects of adolescent cocaine exposure on dendrite structure in the oPFC.
  • To determine if pre-existing cellular characteristics influence behavioral responses to cocaine.
  • To explore the relationship between cocaine-induced structural changes and behavioral vulnerability.

Main Methods:

  • Mice were exposed to cocaine during early adolescence (postnatal days 31-35).
  • Excitatory neurons in the deep-layer oPFC were imaged and reconstructed.
  • Dendritic arbors of orbital neurons were analyzed in both control mice and a genetic model of cocaine vulnerability (p190rhogap+/- mice).

Main Results:

  • Adolescent cocaine exposure resulted in shortened and simplified dendritic arbors in the oPFC, particularly in the basal region.
  • In contrast, drug-naïve p190rhogap+/- mice, which exhibit heightened cocaine sensitivity, showed intact oPFC dendritic arbors.
  • This suggests cocaine-induced structural changes are more critical than baseline structural differences.

Conclusions:

  • Adolescent cocaine exposure induces lasting alterations in oPFC dendrite structure.
  • Cocaine-induced modifications in dendrite structure are likely key contributors to behavioral effects and vulnerability.
  • Pre-existing structural abnormalities in oPFC neurons may play a lesser role in cocaine vulnerability compared to drug-induced changes.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.4K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.6K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.6K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.9K
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
2.0K